Meeting
2023 ASCO Annual Meeting
Genomic targetability and survival outcomes of biliary tract cancers (BTC): A retrospective cohort study of the Australian Molecular Screening and Therapeutics (MoST) program.
Authors
Subotheni Thavaneswaran
Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, NSW, Australia
Subotheni Thavaneswaran , Frank Po-Yen Lin , Christine E Napier , John P. Grady , Mandy L. Ballinger , Maya Kansara , Peter S. Grimison , Nick Pavlakis , Mark Ka Wong , Katrin Marie Sjoquist , David Goldstein , Lorraine A. Chantrill , John Simes , David Morgan Thomas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer - Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4093)
DOI
10.1200/JCO.2023.41.16_suppl.4093
Abstract #
4093
Poster Bd #
414
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Landscape of BRAF mutation classes in intrahepatic cholangiocarcinoma.
First Author: Tin-Yun Tang
Poster
2021 ASCO Annual Meeting
Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data.
First Author: Kumiko Umemoto
Poster
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
First Author: Sunyoung S. Lee
Poster
2020 ASCO Virtual Scientific Program
Genomics and translational precision oncology for 803 patients with biliary tract cancer.
First Author: Jianzhen Lin